BSTC - BioSpecifics Technologies Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue27,443.75226,250.95522,750.135
Cost of Revenue---
Gross Profit27,443.75226,250.95522,750.135
Operating Expenses
Research Development1,223.2771,327.9231,034.288
Selling General and Administrative8,542.3247,896.6167,272.532
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss17,678.15117,026.41614,443.315
Income from Continuing Operations
Total Other Income/Expenses Net687.642348.588107.645
Earnings Before Interest and Taxes18,365.79317,375.00414,550.96
Interest Expense---
Income Before Tax18,365.79317,375.00414,550.96
Income Tax Expense7,037.5276,002.7654,933.328
Minority Interest---
Net Income From Continuing Ops11,328.26611,372.2399,617.632
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income11,328.26611,372.2399,617.632
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares11,328.26611,372.2399,617.632